Insights into the Clinical and Laboratory Characteristics of Pediatric Cystic Fibrosis Patients: a single-center study
Keywords:
Cystic Fibrosis, Sweat Chloride Test, Delt F508, MutationAbstract
Background: Cystic fibrosis (CF) in children is an inherited disorder that causes thick mucus to build up in body and leads  to damage various organs, especially the digestive system and lungs. The predicted incidence of cystic fibrosis fluctuates among ethnic groups, with Caucasians having the greatest prevalence Objective: The objective of the study was to explore the clinical and laboratory profile of children with Cystic Fibrosis. Methodology: This retrospective study was carried out at the Department of Paediatric Medicine, Qazi Hussain Ahmad medical complex Nowshera from August 2021 to January 2022 after obtaining permission from the ethical committee of the institute. Admitted Participants diagnosed with cystic fibrosis based on the positive sweat chloride test and clinical characteristics from birth to fifteen years of both gender were enrolled in this study. Sweat chloride levels above 60 mmol per litre were considered CF Positive. Analyses of the identified Delta F-508 mutations were observed. Sputum culture results and HRCT chest findings from laboratory and radiographic studies were recorded. Analysis of the data was done with SPSS version 20. Results: A total of 47 children were enrolled in the study according to the inclusion criteria. The most prevalent symptom among the study cases was chronic cough (70%). Respiratory features that were most common in our study on chest HRCT included bronchiectasis and hyperinflation (38%). Radiological examination evaluated 27% consolidation. Culture investigation showed that the most prevalent bacteria was Pseudomonas (27%). Gastroenterological features like steatorrhea were seen in 6 (12.7%) patients. Conclusion: In children diagnosed with cystic fibrosis, respiratory symptoms were found to be more prevalent compared to gastrointestinal symptoms. When analyzing their chest CT scans, nearly half of the examined cases showed bronchiectatic changes. Among those investigated, 27% exhibited pseudomonas colonization in their airways. In the present study, the delta F-508 mutation was identified as rare. ÂReferences
Zvereff VV, Faruki H, Edwards M, Friedman KJ. Cystic fibrosis carrier screening in a North American population. Genet Med. 2013;16(7):539-46.
Ren C, Desai H, Platt M, Dixon M. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome. Pediatr Pulmonol. 2011; 46(11):1079-84.
Bertrand CA, Frizzell RA. The role of regulated CFTR trafficking in epithelial secretion. Am J Physiol Cell Physiol. 2003;285(1):C1-18.
Prasad R, Sharma H, Kaur G. Molecular Basis of Cystic Fibrosis Disease: An Indian Perspective. Indian J Clin Biochem. 2010;25(4):335-41.
Shah U, Frossard P, Moatter T. Cystic fibrosis: defining a disease under-diagnosed in Pakistan. Trop Med Int Health. 2009;14(5):542-5.
Chang E Zabner J. Precision Genomic Medicine in Cystic Fibrosis. Clin Transl Sci. 2015;8(5):606-10.
Frossard PM, Girodon E, Dawson KP, Ghanem N, Plassa F, Lestringant GG, et al. Identification of cystic fibrosis mutations in the United Arab Emirates. Mutations in brief no. 133. Online Hum Mutat. 1998;1:412-3.
Kabra SK, Kabra M, Lodha R, Shastri S, Ghosh M, Pandey RM, et al. Clinical profile and frequency of delta f508 mutation in Indian children with cystic fibrosis. Indian Pediatr. 2003;40(7):612-9.
El-Falaki M, Shahin W, El-Basha N, Ali A, Mehaney D, El Attar M. Profile of cystic fibrosis in a single referral center in Egypt. J Adv Res. 2014;5(5):563-8.
Ashraf M, Ahmed K, Chowdhary J, Rehana B, Ahmed J, Mir T. Clinical profile, diagnostic delay, and genetic make-up of cystic fibrosis in Kashmir, India. Lung India. 2011;28(2):97
Desgeorges M, Mégarbané A, Guittard C, Carles S, Loiselet J, Demaille J, et al. Cystic fibrosis in Lebanon: distribution of CFTR mutations among Arab communities. Hum Genet. 1997;100(2):279-283
Naguib M, Schrijver I, Gardner P, Pique LM, Doss SS, Zekry MA, et al. Cystic fibrosis detection in high-risk Egyptian children and CFTR mutation analysis. J Cyst Fibros. 2007;6(2):111-6.
Bhutta ZA, Moattar T, Shah U. Genetic analysis of cystic fibrosis in Pakistan: a preliminary report. J Pak Med Assoc. 2000;50(7):217-9.
Sawicka E, Zybert K. Meconium ileus in newborns with cystic fibrosis− results of treatment in the group of patients operated on in the years 2000-2014. Dev Period Med.2015;(1):32-40.
Mushtaq I, Wright VM, Drake DP, Mearns MB, Wood CB. Meconium ileus secondary to cystic fibrosis. The East London experience. Pediatr Surg Int. 1998;13(5-6):365-9.
Kintu B, Brightwell A. Episodic seasonal pseudo-Bartter syndrome in cystic fibrosis. Paediatr Respir Rev. 2014;15:19.
Ren C, Konstan M, Rosenfeld M, Pasta D, Millar S, Morgan W. Early childhood wheezing is associated with lower lung function in cystic fibrosis. Pediatr Pulmonol.2013;49(8):745-50.
London Jr NR, Reh DD. Differential Diagnosis of Chronic Rhinosinusitis with Nasal Polyps.In Rhinosinusitis with Nasal Polyposis 2016;(79):1-12. Karger Publishers.
Wells J, Farris R, Gosdin T, Dransfield MT, Wood ME, Bell SC, et al. Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study. Lancet Respir Med. 2016;4(8):636-45.
Hayes D, Tobias J, Mansour H, Kirkby S, McCoy KS, Daniels CJ, et al. Pulmonary Hypertension in Cystic Fibrosis with Advanced Lung Disease. Am J Respir Crit Care Med. 2014;190(8):898-905.
McCloskey M, Redmond A, Hill A, Elborn J. Clinical Features Associated with a Delayed Diagnosis of Cystic Fibrosis. Respiration. 2000;67(4):402-7.
Kawoosa MS, Bhat MA, Ali SW, Hafeez I, Shastri S. Clinical and mutation profile of children with cystic fibrosis in Jammu and Kashmir. Indian Pediatr. 2014;51(3):185
Giglio L, Candusso M, D’orazio C, Mastella G, Faraguna D. Failure to thrive: the earliest feature of cystic fibrosis in infants diagnosed by neonatal screening. Acta Paediatrica. 1997;86(11):1162-5.
de Jong PA, Lindblad A, Rubin L, Hop WC, de Jongste JC, Brink M, et al. Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax. 2006; 61(1):80-5.
Coffey MJ, Whitaker V, Gentin N, Junek R, Shalhoub C, Nightingale S et al. Differences in Outcomes between Early and Late Diagnosis of Cystic Fibrosis in the Newborn Screening Era J pediatr. 2017;181:137-45.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pakistan Journal of Chest Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
